New At-Home Blood Test Shows Risk of Developing Preeclampsia

A groundbreaking at-home blood test, Encompass, now offers early detection of preeclampsia risk—one of the most serious pregnancy complications, linked to 46,000 maternal deaths globally each year. Developed by Mirvie, the test analyzes RNA to predict risk months before symptoms arise, allowing for proactive interventions like low-dose aspirin, home blood pressure monitoring, and increased clinical surveillance.

Available to pregnant individuals over 35, Encompass boasts a 90% accuracy rate in identifying high-risk cases and a 99.7% rate in confirming low risk. For public health professionals, this innovation signals a shift toward personalized, preventative prenatal care that could significantly improve maternal and fetal outcomes. Read more from Parents.com here.